Nakamura A.
Glucokinase as a therapeutic target based on findings from the analysis of mouse models.
Endocr J, in press
IF: 2.349
{ 88件 }
Nakamura A.
Glucokinase as a therapeutic target based on findings from the analysis of mouse models.
Endocr J, in press
IF: 2.349
公益財団法人 福田記念医療技術振興財団 論文等表彰事業 優秀賞 亀田 玲奈先生
Shibayama Y, Alkhoury C, Nemazanyy I, Henneman N, Cagnard N, Girard M, Atsumi T, Panasyuk G.
Class 3 Phosphatidyl Inositol-3 Kinase Promotes Hepatic Glucocorticoid Receptor Stability and Transcriptional Activity Acta Physiologica, in press
IF: 6.311
Yuki Oe, Hiroshi Nomoto, Akinobu Nakamura, Saki Kuwabara, Yuka Takahashi, Ayano Yasui, Rimi Izumihara, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Hideaki Miyoshi Switching from insulin degludec plus dipeptidyl peptidase-4 inhibitor to insulin degludec/liraglutide improves glycemic variability in patients with type 2 diabetes: a preliminary prospective observation study J Diabetes Res, in press.
IF: 4.011
Takahashi Y, Kameda H, Miya A, Nomoto H, Nakamura A, Nishimura H, Kimura H, Suzuki M, Konno S, Shimizu A, Matsuno Y, Okamoto M, Motegi H, Iwata N, Fujisawa H, Suzuki A, Sugimura Y, Miyoshi H, A tsumi T.
Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
Pituitary, in press.
IF: 4.107
Oe Y, Kameda H, Nomoto H, Sakamoto K, Soyama T, Cho KY, Nakamura A, Iwasaki K, Abo D, Kudo K, Miyoshi H, Atsumi T.
Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: a case report Medicine, in press
IF: 1.889
第47回日本神経内分泌学会 若手研究奨励賞 関崎 知紀先生
Kamoshima H, Nomoto H, Yamashita K, Takahashi Y, Tsuchida K, Kuwabara S, Miya A, Cho KY, Kameda H, Nakamura A, Atsumi T, Taneda S, Kurihara Y, Aoki S, Ono Y, Miyoshi H.
Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?
Endocrine Journal, in press.
IF: 2.349
Oba-Yamamoto C, Takeuchi J, Nakamura A, Nomoto H, Kameda H, Cho KY, Atsumi T, Miyoshi H Impact of low-starch high-fiber pasta on postprandial blood glucose.
Nutrition, Metabolism and Cardiovascular Diseases, in press.
IF: 4.222
Kawata S, Nakamura A, Miyoshi H, Yang K, Shigesawa I, Yamauchi Y, Tsuchida K, Omori K, Takahashi K, Nomoto H, Kameda H, Cho KY, Terauchi Y, Atsumi T.
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.
Diebetes Obes Metab, in press.
IF: 6.57